Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

648 Results

View

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-7204/7205

Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance

Research Committee(s)

Lymphoma

Activated

04-17-1972

Closed

09-10-1974

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-781

Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's

Activated

02-14-1972

Closed

08-08-1978

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-774/775

Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4)

Activated

07-20-1971

Closed

08-23-1974

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-440

Bleomycin for Solid Tumors and Lymphomas

Activated

12-11-1970

Closed

07-01-1971

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8264

Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma

Activated

08-11-1962

Closed

03-16-1984

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8530

Efficacy of Prednisone in Refractory and Relapsing Multiple Myeloma and Measurement of Glucocorticoid Receptors

Closed

01-01-1990

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8276

Evaluation of m-AMSA VP-16-213 and 5-Azacytidine Combination Chemotherapy in Adult Acute Non-Lymphocytic Leukemia

Closed

01-11-1985

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8510

Intra-Arterial Cis-Platinum and Radiation Therapy in Primary Brain Tumors: A Phase II Randomized Study Comparing Sequential and Combined Treatments.

Closed

11-01-1988